UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Chagas disease: Natural history and diagnosis

Author
Caryn Bern, MD, MPH
Section Editor
Peter F Weller, MD, FACP
Deputy Editor
Elinor L Baron, MD, DTMH

INTRODUCTION

Chagas disease is caused by infection with the protozoan parasite Trypanosoma cruzi; the major manifestations are Chagas cardiomyopathy and gastrointestinal disease [1]. Issues related to the natural history of infection, diagnosis, and clinical circumstances will be reviewed here. Other issues related to Chagas disease, including cardiac and gastrointestinal involvement, are discussed in detail separately. (See related topics.)

NATURAL HISTORY

Transmission — Humans and other mammals usually become infected when the triatomine vector defecates during its blood meal, and fecal material containing the parasite is inoculated through the bite wound or mucous membranes [2]. Transmission can also occur congenitally from mother to infant, via transfusion of blood components, via transplantation of an organ from an infected donor, and via consumption of contaminated food or drink. (See "Chagas disease: Epidemiology and control".)

Acute phase — The incubation period following exposure is one to two weeks, after which the acute phase of Chagas disease begins [3]. In the setting of transfusion- and transplant-associated cases, the incubation period may be as long as four months [4,5].

The acute phase of T. cruzi infection lasts 8 to 12 weeks and is characterized by circulating trypomastigotes detectable by microscopy of fresh blood or buffy coat smears (picture 1). Most patients have nonspecific symptoms (such as malaise, fever, and anorexia) or are asymptomatic so do not come to clinical attention during the acute phase.

In a minority of patients, acute infection may be associated with inflammation and swelling at the site of inoculation, known as a chagoma. Chagomas typically occur on the face or extremities; in some cases, parasites can be demonstrated in the lesion. Inoculation via the conjunctiva may lead to a characteristic unilateral swelling of the upper and lower eyelid known as Romaña's sign (picture 2).

              

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Thu Jun 02 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' Disease in the United States. Clin Microbiol Rev 2011; 24:655.
  2. Maguire JH. Trypanosoma. In: Infectious Diseases, 2nd ed, Gorbach S, Bartlett J, Blacklow N (Eds), Lippincott, Williams & Wilkins, Philadelphia 2004.
  3. Bern C. Chagas' Disease. N Engl J Med 2015; 373:456.
  4. Centers for Disease Control and Prevention (CDC). Chagas disease after organ transplantation--United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51:210.
  5. Kun H, Moore A, Mascola L, et al. Transmission of Trypanosoma cruzi by heart transplantation. Clin Infect Dis 2009; 48:1534.
  6. Acquatella H. Echocardiography in Chagas heart disease. Circulation 2007; 115:1124.
  7. Secretaria de Vigilancia em Saude de Brasil. Doenca de Chagas Aguda. Nota Tecnica, 9 de outubro de 2007. Brasilia, Brasil, 2007.
  8. Beltrão Hde B, Cerroni Mde P, Freitas DR, et al. Investigation of two outbreaks of suspected oral transmission of acute Chagas disease in the Amazon region, Para State, Brazil, in 2007. Trop Doct 2009; 39:231.
  9. Bern C, Verastegui M, Gilman RH, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis 2009; 49:1667.
  10. Torrico F, Alonso-Vega C, Suarez E, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg 2004; 70:201.
  11. Sosa-Estani S. [Congenital transmission of Trypanosoma cruzi infection in Argentina]. Rev Soc Bras Med Trop 2005; 38 Suppl 2:29.
  12. Schijman AG. Congenital Chagas Disease. In: Congenital and Other Related Infectious Diseases of the Newborn, Mushahwar IK (Ed), Elsevier, Amsterdam, Netherlands 2006. Vol 13, p.223.
  13. Centers for Disease Control and Prevention (CDC). Congenital transmission of Chagas disease - Virginia, 2010. MMWR Morb Mortal Wkly Rep 2012; 61:477.
  14. Sánchez Negrette O, Mora MC, Basombrío MA. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 2005; 115:e668.
  15. WHO Expert Committee. Control of Chagas Disease. World Health Organization, Brasilia, Brazil 2002. p. 1.
  16. Ministério da Saúde. Secretaria de Vigilância em Saúde. [Brazilian Consensus on Chagas disease]. Rev Soc Bras Med Trop 2005; 38 Suppl 3:7.
  17. Bern C, Montgomery SP, Herwaldt BL, et al. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA 2007; 298:2171.
  18. Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, et al. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol 1998; 65:261.
  19. Genovese O, Ballario C, Storino R, et al. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr 1996; 54:190.
  20. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant 2007; 7:1633.
  21. Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis 1999; 29:561.
  22. Fontes Rezende RE, Lescano MA, Zambelli Ramalho LN, et al. Reactivation of Chagas' disease in a patient with non-Hodgkin's lymphoma: gastric, oesophageal and laryngeal involvement. Trans R Soc Trop Med Hyg 2006; 100:74.
  23. Kohl S, Pickering LK, Frankel LS, Yaeger RG. Reactivation of Chagas' disease during therapy of acute lymphocytic leukemia. Cancer 1982; 50:827.
  24. Metze K, Lorand-Metze I, De Almeida EA, De Moraes SL. Reactivation of Chagas' myocarditis during therapy of Hodgkin's disease. Trop Geogr Med 1991; 43:228.
  25. Altclas J, Sinagra A, Dictar M, et al. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 2005; 36:123.
  26. Bacal F, Silva CP, Bocchi EA, et al. Mychophenolate mofetil increased chagas disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant 2005; 5:2017.
  27. Bocchi EA, Bellotti G, Mocelin AO, et al. Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg 1996; 61:1727.
  28. Campos SV, Strabelli TM, Amato Neto V, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant 2008; 27:597.
  29. Fiorelli AI, Stolf NA, Honorato R, et al. Later evolution after cardiac transplantation in Chagas' disease. Transplant Proc 2005; 37:2793.
  30. Marchiori PE, Alexandre PL, Britto N, et al. Late reactivation of Chagas' disease presenting in a recipient as an expansive mass lesion in the brain after heart transplantation of chagasic myocardiopathy. J Heart Lung Transplant 2007; 26:1091.
  31. Sartori AM, Ibrahim KY, Nunes Westphalen EV, et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 2007; 101:31.
  32. Wegner DH, Rohwedder RW. The effect of nifurtimox in acute Chagas' infection. Arzneimittelforschung 1972; 22:1624.
  33. Herwaldt BL. Laboratory-acquired parasitic infections from accidental exposures. Clin Microbiol Rev 2001; 14:659.
  34. Schijman AG, Vigliano C, Burgos J, et al. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant 2000; 19:1114.
  35. Feilij H, Muller L, Gonzalez Cappa SM. Direct micromethod for diagnosis of acute and congenital Chagas' disease. J Clin Microbiol 1983; 18:327.
  36. Luquetti AO, Dias JC, Prata A. [Diagnosis and treatment of congenital infection caused by Trypanosoma cruzi in Brazil]. Rev Soc Bras Med Trop 2005; 38 Suppl 2:27.
  37. Duffy T, Bisio M, Altcheh J, et al. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis 2009; 3:e419.
  38. Russomando G, de Tomassone MM, de Guillen I, et al. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 1998; 59:487.
  39. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop 2003; 36:767.
  40. Jackson Y, Myers C, Diana A, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis 2009; 15:601.
  41. Muñoz J, Portús M, Corachan M, et al. Congenital Trypanosoma cruzi infection in a non-endemic area. Trans R Soc Trop Med Hyg 2007; 101:1161.
  42. Sosa-Estani S, Gamboa-León MR, Del Cid-Lemus J, et al. Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico. Am J Trop Med Hyg 2008; 79:755.
  43. Verani JR, Seitz A, Gilman RH, et al. Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg 2009; 80:410.
  44. Umezawa ES, Bastos SF, Camargo ME, et al. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 1999; 37:1554.
  45. Tarleton RL, Reithinger R, Urbina JA, et al. The challenges of Chagas Disease-- grim outlook or glimmer of hope. PLoS Med 2007; 4:e332.
  46. Silveira-Lacerda EP, Silva AG, Junior SF, et al. Chagas' disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang 2004; 87:204.
  47. Leiby DA, Wendel S, Takaoka DT, et al. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J Clin Microbiol 2000; 38:639.
  48. Junqueira AC, Chiari E, Wincker P. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. Trans R Soc Trop Med Hyg 1996; 90:129.
  49. Basquiera AL, Sembaj A, Aguerri AM, et al. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003; 89:1186.
  50. Wincker P, Telleria J, Bosseno MF, et al. PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serological and parasitological diagnosis. Parasitology 1997; 114 ( Pt 4):367.
  51. Hoff R, Mott KE, Silva JF, et al. Prevalence of parasitemia and seroreactivity to Trypanosoma cruzi in a rural population of Northeast Brazil. Am J Trop Med Hyg 1979; 28:461.
  52. Sosa Estani S, Segura EL, Ruiz AM, et al. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 1998; 59:526.
  53. Williams JE. Leishmania and Trypanosoma. In: Medical Parasitology: A Practical Approach, Gillespie SH, Hawkey PM (Eds), Oxford University Press, Oxford, UK 2009. p.151.
  54. de Andrade AL, Zicker F, de Oliveira RM, et al. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348:1407.
  55. Molina I, Gómez i Prat J, Salvador F, et al. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease. N Engl J Med 2014; 370:1899.
  56. Drugs for Neglected Disease Initiative. Chagas disease: DNDi Strategy, 2010. http://www.treatchagas.org/rd_dndi_strategy.aspx (Accessed on March 10, 2010).